HIGHLY SELECTIVE BETA-ADRENOBLOCKER BISOPROLOL IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED CLINICAL CONDITIONS
About the Author
A. N. BritovRussian Federation
References
1. Flemmer, M. C.; Vinik, A.I. Evidence-based therapy for type 2 diabetes. The best and worst of times. Postgrad Med 2000,107(5):27-47
2. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. Eur Heart J. 1985;6:199-226.
3. Herlitz J, Hartford M, Pennert K, et al. Goteborg Metoprolol Trial: clinical observations. Am J Cardiol. 1984;53(13):37D-45D.
4. Ko DT, Hebert PR, Coffey CS, Curtis JP, Foody JM, Sedrakyan A, Krumholz HM. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med. 2004 Jul 12;164(13):1389-94
Review
For citations:
Britov A.N. HIGHLY SELECTIVE BETA-ADRENOBLOCKER BISOPROLOL IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED CLINICAL CONDITIONS. Russian Journal of Cardiology. 2011;(4):114-118. (In Russ.)